NCT06081452

Brief Summary

A brief survey for the public to determine interest in health surveillance and disease detection

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 17, 2023

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

October 6, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 13, 2023

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 17, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 17, 2025

Completed
Last Updated

January 28, 2025

Status Verified

January 1, 2025

Enrollment Period

2 years

First QC Date

October 6, 2023

Last Update Submit

January 27, 2025

Conditions

CancerDiseaseHealth BehaviorHealth AttitudeHealth-Related BehaviorHealth Knowledge, Attitudes, Practice

Outcome Measures

Primary Outcomes (1)

  • Acceptability of breath testing

    Proportion of people that find breath testing an acceptable means to determine health or disease

    6 months

Study Arms (1)

Public

General public to be approached to answer this survey via GPs, charities and exhibitions such as Great Exhibition Road Festival.

Behavioral: Survey

Interventions

SurveyBEHAVIORAL

Members of the public will be asked to complete a survey that collects information on individuals perception of health and disease and their views on breath testing.

Public

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Our aim is to acquire a wide breadth of information from all members of the public, irrespective of the demographics, socioeconomic status and ethnicity. All member of the public, above the age of 18 are welcome to participate

You may qualify if:

  • Member of the public above the age of 18

You may not qualify if:

  • Member of the public below the age of 18

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Imperial College London

London, United Kingdom

RECRUITING

MeSH Terms

Conditions

NeoplasmsDiseaseHealth BehaviorBehavior

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • George Hanna, PhD

    Imperial College London

    STUDY DIRECTOR

Central Study Contacts

Pallavi Huma Arya

CONTACT

02075948197h.arya@imperial.ac.uk

Munir Tarazi

CONTACT

m.tarazi@imperial.ac.uk

Study Design

Study Type
observational
Observational Model
ECOLOGIC OR COMMUNITY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 6, 2023

First Posted

October 13, 2023

Study Start

June 17, 2023

Primary Completion

June 17, 2025

Study Completion

October 17, 2025

Last Updated

January 28, 2025

Record last verified: 2025-01

Locations

GB(1)